QA: OPIANT PHARMACEUTICALS INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2019_OPIANT_PHARMACEUTICALS_INC.pdf

Logs

Graph

Absolute values for 0001385508, OPIANT PHARMACEUTICALS INC.

  xvar xval
0 AssetsCurrent 29,370,578
1 IntangibleAssetsNetIncludingGoodwill 15,746
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 9,827,058
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,700,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,263,804
9 ResearchAndDevelopmentExpense 8,478,817
10 remainder_Expenses 15,481,279
11 remainder_Revenues 13,982,177
12 remainder_NetIncome 46,407
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 29,386,324
1 Liabilities 12,527,058
2 Expenses 35,223,900
3 Revenues 13,982,177
4 StockholdersEquity 16,859,266
5 NetIncome -21,195,316
6 ComprehensiveNetIncome -21,195,316
7 BaseVar 45,582,933
8 EconomicCapitalRatio 0.372

Edgar->Model Mapping

Feature Distribution

Change over Time